Бетоптик Drug photo

The description is actual on 09.05.2016

  • Latin name: Betoptic
  • ATH code: S01ED02
  • Active ingredient: Betaksolol
  • Producer: Alcon-Couvreur N.V. S.A. (Belgium)


Betoptik contains in 1 ml of eye drops 5 mg of active agent betaksolol contain. Additional components are: chloride benzalkoniya, solution of sodium hydroxide or chlorohydrogen acid, clear water.

Release form

Betoptik is issued in the form of eye drops.

Pharmacological action

Glaucoma medicine.

Pharmacodynamics and pharmacokinetics

The main, actively active ingredient is betaksolol. Effect of drug is directed to decrease in indicators of intraocular pressure, betaksolol practically does not make resorptive impact, does not cause a miosis.

Betoptik does not cause a hemeralopia, an accommodation spasm thanks to decrease in production of watery moisture.

Unlike miotik does not cause effect "a veil and fog" before eyes.

Effective action lasts days.

Indications to use

Betoptik appoint with the increased intraocular pressure, at treatment of an open-angle form of glaucoma, after carrying out a laser form of a trabekuloplastika.


Betoptik do not apply at a sinus bradycardia, hypersensitivity to a betaksolol, an atrioventricular block 2-3 degrees, a chronic form of heart failure in a decompensation stage.

At a diabetes mellitus, Reynaud's syndrome, reception of beta adrenoblockers, a tireotiksikoza, breastfeeding, pregnancy, in pediatrics apply with care.

Side effects

Among system side reactions from administration of drug Betoptik is marked out depressive neurosis, sleeplessness.

Local reactions: photophobia, an anisocoria, a conjunctiva itch, an allergy, dacryagogue, discomfort in eyes, a keratitis.

Eye drops Betoptik, application instruction (Way and dosage)

Drops Betoptik apply locally: on 1 drop of drug dig in in a conjunctival sac twice a day.

The first month of treatment is spent under regular control of intraocular pressure.


If a large amount of drug got into eyes, it is necessary to wash out carefully them flowing water.


The risk of development of the additive effects increases at a concomitant use of drug Betoptik and peroral forms of beta adrenoblockers. The additive action is shown concerning the intraocular pressure and system influence of beta adrenoblockers. Reserpinum and other drugs oppressing deposition of catecholamines at simultaneous use with betaksololy increase risk of bradycardia, reduce arterial pressure.

Terms of sale

The recipe is required.

Storage conditions

In the place, unavailable to children, in vertical position at a temperature of 8-30 degrees Celsius.

Period of validity

No more than three years.

Special instructions

Topical administration of drug can cause development of system side effects.

During the entire period of therapy carrying contact lenses is contraindicated.

At a closed-angle form of glaucoma of a drop appoint in a combination from miotika.

Betoptik does not influence pupil size.

Transition from protivoglaukomny means on betaksolol has to be carried out gradually. In

the period of breastfeeding, pregnancy use of drops is allowed only in cases of excess of therapeutic effect over possible negative influence on a fruit.

Drug influences management of motor transport, difficult mechanisms.

Betoptik's analogs

Coincidence on the ATH code of the 4th level:

Analogs it is possible to call: Lokren, Betoftan, Ksonef.


  • Betoptik of 0,5% of a drop eye 5 ml bottle-kapelnitsaalcon
  • Betoptik From 0,25% of a drop eye 5 ml a bottle-kapelnitsaalcon

Drugstore of IFC

  • Betoptik of an eye. cap of 0.5% fl 5 ml, Alcon-Couvreurbelgiya
  • Betoptik From eyes. cap of 0.25% fl 5 ml, Alcon-Couvreurbelgiya
to show still


  • Betoptik SAlcon-Couvreur (Belgium)


  • Betoptik From 0,25% 5 ml susp.glazn.
to show still
Section: For eyes
in more detail

Education: Graduated from the Bashkir state medical university majoring in "Medical business". In 2011 gained the diploma and the certificate in Therapy. In 2012 received 2 certificate and the diploma in "Functional diagnosis" and "Cardiology". In 2013 completed courses on "Topical issues of otorhinolaryngology in therapy". In 2014 completed advanced training courses in "A clinical echocardiography" and courses in "Medical rehabilitation".

Experience: From 2011 to 2014 the Policlinic No. 33 Ufa worked as the therapist and the cardiologist in MBUZ. Since 2014 the Policlinic No. 33 Ufa works as the cardiologist and the doctor of functional diagnosis in MBUZ.

PAY ATTENTION! Information on drugs on the website is help generalizing, collected from public sources and can form the basis for making decision on use of medicines it is not aware of treatment. Before medicine use Betoptik surely consult with the attending physician.